5 Small Drug Stocks to Buy as Tariff-Related Uncertainty Looms

The biotech industry has been under pressure due to the global uncertainty caused by the tariff war. Though pharmaceuticals have been exempted in the first round of reciprocal tariffs, they could well be Trump’s target in the next round. Though the Trump administration has implemented a 90-day pause on all trading partners, excluding China, when imposed, tariffs on pharmaceutical imports can lead to potential disruptions to global supply chains and increased production costs.Biotech stocks have been under p ...